One Health Model

Last updated
One Health Triad One Health Triad.jpg
One Health Triad

The concept of One Health is the unity of multiple practices that work together locally, nationally, and globally to help achieve optimal health for people, animals, and the environment. When the people, animals, and environment are put together they make up the One Health Triad . [2] The One Health Triad shows how the health of people, animals, and the environment is linked to one another. [2] With One Health being a worldwide concept, it makes it easier to advance health care in the 21st century. [3] When this concept is used, and applied properly, it can help protect people, animals, and the environment in the present and future generations. [3]

Contents

Background

The origins of the One Health Model dates as far back as 1821, with the first links between human and animal diseases being recognized by Rudolf Virchow. Virchow noticed links between human and animal disease, coining the term "zoonosis." The major connection Virchow made was between Trichinella spiralis in swine and human infections. [4] It was over a century later before the ideas laid out by Virchow were integrated into a single health model connecting human health with animal health.

In 1964, Dr. Calvin Schwabe, a former member of World Health Organization (WHO) and the founding chair of Department of Epidemiology and Preventive Medicine at the Veterinary School at the University of California Davis, called for a "One Medicine" model emphasizing the need for collaboration between human and wildlife pathologists as a means of controlling and even preventing disease spread. [5] It would be another four decades before the One Health became a reality with the 12 Manhattan Principles, where human and animal pathologists called for "One Health, One World." [5] [6]

The One Health Model has gained momentum in recent years due to the discovery of the multiple interconnections that exist between animal and human disease. Recent estimates place zoonotic diseases as the source 60% of total human pathogens, and 75% of emerging human pathogens. [7]

Applying the One Health Model

The One Health Model can constantly be applied with human and animal interactions. One of the main situations where One Health can be applied is with canine and feline obesity being linked to their owners and their own obesity. [8] Obesity in canines and felines is not good for them nor is it good for humans. The obesity of humans and their animals can result in many health problems such as diabetes mellitus, osteoarthritis, and many others. [8] In some cases if the obesity of the pet is too bad the pet may be removed from its owner and put up for adoption. [8] The only solution for this issue is to encourage owners to have a healthy lifestyle for both them and their animals. [8] Zoonotic Diseases is another situation that the One Health model can be applied to. This is talked about more in the Zoonotic Disease section.

One Health and Antibiotic Resistance

Antibiotic resistance is becoming a serious problem in today's agriculture industry and for humans. One reason for this occurring resistance is that natural resistomes are present in different environmental niches. [9] These environmental resistomes function as an antibiotic resistance gene. [9] There are many questions and research that needs to be further done to find out if these environmental resistomes play a big role in the antibiotic resistance that is occurring in humans, animals, and plants. [9] A recent study was done and reported that 700 000 annual deaths were caused by infections due to drug resistant pathogens [10] This study also reported that if unchecked, this number will increase to 10 million by 2050. [10] The National Antimicrobial Monitoring System is a system used to monitor antimicrobial resistance among bacteria that is isolated from animals that are used as food [11]

In 2013, they found that about 29% of turkeys, 18% of swine, 17% of beef, and 9% of chicken were multi drug resistant, meaning they had resistance to 3 or more classes of antimicrobials. [11] Having this resistance for both animals and humans makes it easier for zoonotic diseases to be transferred between them and also makes it easier for the resistance of these antimicrobials to be passed on. [12] With this being said, there are many possible risk management options that can be taken to help reduce this possibility. [13] Most of these risk management options can take place on the farm or at the slaughter house for animals. [13] When it comes to humans, risk management has to be done by you yourself and you have to be responsible for good hygiene, up to date vaccinations, and proper use of antibiotics. [14] [15] With that being said, the same management on farms needs to be taken for proper use of antibiotics and only using them when it is absolutely necessary and improving the general hygiene in all stages of production. [13] With these management factors added in with research and knowledge on the amount of resistance within our environment, antimicrobial resistance may be able to be controlled and help reduce the amount of zoonotic diseases that are passed between animals and humans. [13]

Zoonotic Diseases and One Health

Zoonosis or zoonotic disease can be defined as an infectious disease that can be transmitted between animals and humans. [16] One Health plays a big role in helping to prevent and control zoonotic diseases. [17] Approximately 75% of new and emerging infectious diseases in humans are defined as zoonotic. [17] Zoonotic diseases can be spread in many different ways. [18] The most common known ways they are spread are through direct contact, indirect contact, vector-borne, and food-borne. [18] Below in (Table 1) you can see a list of different zoonotic diseases, their main reservoirs, and their mode of transmission.

Table 1: Zoonotic Diseases

DiseaseMain reservoirsUsual mode of transmission to humans
Anthraxlivestock, wild animals, environmentdirect contact, ingestion
Animal influenzalivestock, humansmay be reverse zoonosis
Avian influenzapoultry, ducksdirect contact
Bovine tuberculosiscattlemilk
Brucellosiscattle, goats, sheep, pigsdairy products, milk
Cat scratch fevercatsbite, scratch
COVID-19not yet knownnot yet known
Cysticercosiscattle, pigsmeat
Cryptosporidiosiscattle, sheep, petswater, direct contact
Enzootic abortionfarm animals, sheepdirect contact, aerosol
Erysipeloidpigs, fish, environmentdirect contact
Fish tank granulomafishdirect contact, water
Campylobacterpoultry, farm animalsraw meat, milk
Salmonellapoultry, cattle, sheep, pigsfoodborne
Giardiasishumans, wildlifewaterborne, person to person
Glandershorse, donkey, muledirect contact
Haemorrhagic colitisruminantsdirect contact (and foodborne)
Hantavirus syndromesrodentsaerosol
Hepatitis Enot yet knownnot yet known
Hydatid diseasedogs, sheepingestion of eggs excreted by dog
Leptospirosisrodents, ruminantsinfected urine, water
Listeriosiscattle, sheep, soildairy produce, meat products
Louping illsheep, grousedirect contact, tick bite
Lyme diseaseticks, rodents, sheep, deer, small mammalstick bite
Lymphocytic choriomeningitisrodentsdirect contact
Orfsheepdirect contact
Pasteurellosisdogs, cats, many mammalsbite/scratch, direct contact
Plaguerats and their fleasflea bite
Psittacosisbirds, poultry, ducksaerosol, direct contact
Q fevercattle, sheep, goats, catsaerosol, direct contact, milk, fomites
Rabiesdogs, foxes, bats, cats animalbite
Rat bite fever (Haverhill fever)ratsbite/scratch, milk, water
Rift Valley fevercattle, goats, sheepdirect contact, mosquito bite
Ringwormcats, dogs, cattle, many animal speciesdirect contact
Streptococcal sepsispigsdirect contact, meat
Streptococcal sepsishorses, cattledirect contact, milk
Tickborne encephalitisrodents, small mammals, livestocktickbite, unpasteurised milk products
Toxocariasisdogs, catsdirect contact
Toxoplasmosiscats, ruminantsingestion of faecal oocysts, meat
Trichinellosispigs, wild boarpork products
Tularemiarabbits, wild animals, environment, ticksdirect contact, aerosol, ticks, inoculation
Ebola, Crimean-Congo HF, Lassa and Marburg virusesvariously: rodents, ticks, livestock, primates, batsdirect contact, inoculation, ticks
West Nile feverwild birds, mosquitoesmosquito bite
Zoonotic diphtheriacattle, farm animals, dogsdirect contact, milk

[19]

See also

Related Research Articles

<span class="mw-page-title-main">Antimicrobial resistance</span> Resistance of microbes to drugs directed against them

Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms that protect them from the effects of antimicrobials. All classes of microbes can evolve resistance where the drugs are no longer effective. Fungi evolve antifungal resistance, viruses evolve antiviral resistance, protozoa evolve antiprotozoal resistance, and bacteria evolve antibiotic resistance. Together all of these come under the umbrella of antimicrobial resistance. Microbes resistant to multiple antimicrobials are called multidrug resistant (MDR) and are sometimes referred to as superbugs. Although antimicrobial resistance is a naturally occurring process, it is often the result of improper usage of the drugs and management of the infections.

<span class="mw-page-title-main">Zoonosis</span> Disease that can be transmitted from other species to humans

A zoonosis or zoonotic disease is an infectious disease of humans caused by a pathogen that can jump from a non-human to a human and vice versa.

<span class="mw-page-title-main">Epidemic</span> Rapid spread of disease affecting a large number of people in a short time

An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.

<span class="mw-page-title-main">Natural reservoir</span> Type of population in infectious disease ecology

In infectious disease ecology and epidemiology, a natural reservoir, also known as a disease reservoir or a reservoir of infection, is the population of organisms or the specific environment in which an infectious pathogen naturally lives and reproduces, or upon which the pathogen primarily depends for its survival. A reservoir is usually a living host of a certain species, such as an animal or a plant, inside of which a pathogen survives, often without causing disease for the reservoir itself. By some definitions a reservoir may also be an environment external to an organism, such as a volume of contaminated air or water.

<span class="mw-page-title-main">Emerging infectious disease</span> Infectious disease of emerging pathogen, often novel in its outbreak range or transmission mode

An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently, and could increase in the near future. The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal, as well as clinical. EIDs have been increasing steadily since at least 1940.

The resistome has been used to describe to two similar yet separate concepts:

A reverse zoonosis, also known as a zooanthroponosis or anthroponosis, is a pathogen reservoired in humans that is capable of being transmitted to non-human animals.

Campylobacter upsaliensis is a gram-negative bacteria in the Campylobacter genus. C. upsaliensis is found worldwide, and is a common cause of campylobacteriosis in humans, as well as gastroenteritis in dogs and cats. Human infections are primarily associated with raw or undercooked meat and contaminated water sources, however there is some zoonotic risk associated with the spread from dogs and cats. C. upsaliensis primarily affects the gastrointestinal tract as it damages gastrointestinal epithelial cells. There are many methods for detecting C.upsaliensis including PCR and ELISA, however there is no current gold standard in detection techniques. Infection is typically self limiting, however there is antimicrobial therapy available.

<span class="mw-page-title-main">Disease vector</span> Agent that carries and transmits an infectious pathogen into another living organism

In epidemiology, a disease vector is any living agent that carries and transmits an infectious pathogen such as a parasite or microbe, to another living organism. Agents regarded as vectors are mostly blood-sucking insects such as mosquitoes. The first major discovery of a disease vector came from Ronald Ross in 1897, who discovered the malaria pathogen when he dissected the stomach tissue of a mosquito.

<span class="mw-page-title-main">Antibiotic misuse</span>

Antibiotic misuse, sometimes called antibiotic abuse or antibiotic overuse, refers to the misuse or overuse of antibiotics, with potentially serious effects on health. It is a contributing factor to the development of antibiotic resistance, including the creation of multidrug-resistant bacteria, informally called "super bugs": relatively harmless bacteria can develop resistance to multiple antibiotics and cause life-threatening infections.

<span class="mw-page-title-main">One Health</span>

One Health is an approach calling for "the collaborative efforts of multiple disciplines working locally, nationally, and globally, to attain optimal health for people, animals and our environment", as defined by the One Health Initiative Task Force (OHITF). It developed in response to evidence of the spreading of zoonotic diseases between species and increasing awareness of "the interdependence of human and animal health and ecological change". In this viewpoint, public health is no longer seen in purely human terms. Due to a shared environment and highly conserved physiology, animals and humans not only suffer from the same zoonotic diseases, but can also be treated by either structurally related or identical drugs. For this reason, special care must be taken to avoid unnecessary or over-treatment of zoonotic diseases, particularly in the context of drug resistance in infectious microbes.

<span class="mw-page-title-main">Subtherapeutic antibiotic use in swine</span>

Antibiotics are commonly used in commercial swine production in the United States and around the world. They are used for disease treatment, disease prevention and control, and growth promotion. When used for growth promoting purposes, antibiotics are given at low concentrations for long periods of time. Low concentration of antibiotics, also referred to as subtherapeutic (STA), are given as feed and water additives which improve daily weight gain and feed efficiency through alterations in digestion and disease suppression. Additionally, the use of STA in swine results in healthier animals and reduces the “microbial load” on meat resulting in an assumed decrease in potential Foodborne illness risk. While the benefits of subtherapeutic antibiotic administration are well-documented, there is much concern and debate regarding the development of bacterial antibiotic resistance associated with their use.

Staphylococcus schleiferi is a Gram-positive, cocci-shaped bacterium of the family Staphylococcaceae. It is facultatively anaerobic, coagulase-variable, and can be readily cultured on blood agar where the bacterium tends to form opaque, non-pigmented colonies and beta (β) hemolysis. There exists two subspecies under the species S. schleiferi: Staphylococcus schleiferi subsp. schleiferi and Staphylococcus schleiferi subsp. coagulans.

Staphylococcus pseudintermedius is a gram positive coccus bacteria of the genus Staphylococcus found worldwide. It is primarily a pathogen for domestic animals, but has been known to affect humans as well. S. pseudintermedius is an opportunistic pathogen that secretes immune modulating virulence factors, has many adhesion factors, and the potential to create biofilms, all of which help to determine the pathogenicity of the bacterium. Diagnoses of Staphylococcus pseudintermedius have traditionally been made using cytology, plating, and biochemical tests. More recently, molecular technologies like MALDI-TOF, DNA hybridization and PCR have become preferred over biochemical tests for their more rapid and accurate identifications. This includes the identification and diagnosis of antibiotic resistant strains.

<span class="mw-page-title-main">Antibiotic use in livestock</span> Use of antibiotics for any purpose in the husbandry of livestock

Antibiotic use in livestock is the use of antibiotics for any purpose in the husbandry of livestock, which includes treatment when ill (therapeutic), treatment of a group of animals when at least one is diagnosed with clinical infection (metaphylaxis), and preventative treatment (prophylaxis). Antibiotics are an important tool to treat animal as well as human disease, safeguard animal health and welfare, and support food safety. However, used irresponsibly, this may lead to antibiotic resistance which may impact human, animal and environmental health.

<span class="mw-page-title-main">Feline zoonosis</span> Medical condition

A feline zoonosis is a viral, bacterial, fungal, protozoan, nematode or arthropod infection that can be transmitted to humans from the domesticated cat, Felis catus. Some of these diseases are reemerging and newly emerging infections or infestations caused by zoonotic pathogens transmitted by cats. In some instances, the cat can display symptoms of infection and sometimes the cat remains asymptomatic. There can be serious illnesses and clinical manifestations in people who become infected. This is dependent on the immune status and age of the person. Those who live in close association with cats are more prone to these infections, but those that do not keep cats as pets can also acquire these infections as the transmission can be from cat feces and the parasites that leave their bodies.

ESKAPE is an acronym comprising the scientific names of six highly virulent and antibiotic resistant bacterial pathogens including: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. The acronym is sometimes extended to ESKAPEE to include Escherichia coli. This group of Gram-positive and Gram-negative bacteria can evade or 'escape' commonly used antibiotics due to their increasing multi-drug resistance (MDR). As a result, throughout the world, they are the major cause of life-threatening nosocomial or hospital-acquired infections in immunocompromised and critically ill patients who are most at risk. P. aeruginosa and S. aureus are some of the most ubiquitous pathogens in biofilms found in healthcare. P. aeruginosa is a Gram-negative, rod-shaped bacterium, commonly found in the gut flora, soil, and water that can be spread directly or indirectly to patients in healthcare settings. The pathogen can also be spread in other locations through contamination, including surfaces, equipment, and hands. The opportunistic pathogen can cause hospitalized patients to have infections in the lungs, blood, urinary tract, and in other body regions after surgery. S. aureus is a Gram-positive, cocci-shaped bacterium, residing in the environment and on the skin and nose of many healthy individuals. The bacterium can cause skin and bone infections, pneumonia, and other types of potentially serious infections if it enters the body. S. aureus has also gained resistance to many antibiotic treatments, making healing difficult. Because of natural and unnatural selective pressures and factors, antibiotic resistance in bacteria usually emerges through genetic mutation or acquires antibiotic-resistant genes (ARGs) through horizontal gene transfer - a genetic exchange process by which antibiotic resistance can spread.

Antibiotic use in the United States poultry farming industry is the controversial prophylactic use of antibiotics in the country's poultry farming industry. It differs from the common practice in Europe, where antibiotics for growth promotion were disallowed in the 1950s.

Laura H. Kahn is a native Californian. She is an author, lecturer, a general internist physician, and a research scholar with the Program on Science and Global Security at the Woodrow Wilson School of Public and International Affairs at Princeton University in New Jersey. She is the co-founder, of One Health Initiative. She is an online columnist for the Bulletin of the Atomic Scientists. She is an expert advisor and author in the field of zoonosis. Zoonosis is the study of infectious diseases where cross-species illnesses that are caused by bacteria, viruses, or parasites spread from non-human animals to humans. She is the author of Who's in Charge? Leadership During Epidemics, Bioterror Attacks, and Other Public Health Crises

An occupational infectious disease is an infectious disease that is contracted at the workplace. Biological hazards (biohazards) include infectious microorganisms such as viruses, bacteria and toxins produced by those organisms such as anthrax.

References

  1. "OPINION: DO WE NEED TO INDUCE STRESS in the ONE-HEALTH PARADIGM?". THE OUTBREAK. 2013-10-16. Retrieved 2017-04-05.
  2. 1 2 "One Health - It's all connected". avma.org. Retrieved 31 March 2017.
  3. 1 2 "About the One Health Initiative". onehealthinitiative.com. Retrieved 31 March 2017.
  4. Schultz, Myron (2008). "Rudolf Virchow". Emerg Infect Dis. 14 (9): 1480–1481. doi:10.3201/eid1409.086672. PMC   2603088 .
  5. 1 2 "History of One Health". Cdc.gov. Retrieved 2 December 2014.
  6. "The Manhattan Principles As defined during the meeting titled Building Interdisciplinary Bridges to Health in a "Globalized World" held in 2004" (PDF). Cdc.gov. Retrieved 2 December 2014.
  7. "Zoonotic Disease: When Humans and Animals Intersect". Cdc.gov. Retrieved 2 December 2014.
  8. 1 2 3 4 Sandoe, Peter (December 20, 2014). "Canine and feline obesity: a One Health perspective" (PDF). Veterinary Record. 175 (24): 610–616. doi:10.1136/vr.g7521. PMID   25523996. S2CID   27828358.
  9. 1 2 3 Atlans, Ronald M. (2014). One Health: People, Animals, and the Environment. Washington, DC: ASM Press. pp. 185–197. ISBN   978-1-55581-842-5.
  10. 1 2 Robinson, T.P. (5 August 2016). "Antibiotic resistance is the quintessential One Health issue". Trans R Soc Trop Med Hyg. 110 (7): 377–380. doi:10.1093/trstmh/trw048. PMC   4975175 . PMID   27475987 via Oxford University Press.
  11. 1 2 "About Antibiotic Resistance and One Health Antibiotic Stewardship". Minnesota Department of Health. 30 March 2017. Retrieved 3 April 2017.
  12. Antimicrobial Resistance in Zoonotic Bacteria and Foodborne Pathogens. Washington, DC: American Society For Microbiology. 2008. pp. 12–13.
  13. 1 2 3 4 Choffnes, Eileen R. (2012). Improving Food Safety Through a One Health Approach: Workshop Summary. Washington, DC: The National Academies Press. pp. A15. ISBN   978-0-309-25933-0.
  14. Editor., Nyhus, Philip J., Contribution by. McCarthy, Tom, Volume Editor. Mallon, David, Volume (June 2016). Snow Leopards: Biodiversity of the World: Conservation from Genes to Landscapes. Academic Press [Imprint]. ISBN   978-0-12-802213-9. OCLC   972571184.{{cite book}}: |last= has generic name (help)CS1 maint: multiple names: authors list (link)
  15. Canada, Public Health Agency of. "Prevention of antibiotic resistance - Canada.ca". www.canada.ca. Retrieved 2017-04-04.
  16. "Zoonotic Diseases: Disease Transmitted from Animals to Humans - Minnesota Dept. of Health". www.health.state.mn.us. Retrieved 2017-04-05.
  17. 1 2 Bidaisee, Satesh; Macpherson, Calum N. L. (2014-01-01). "Zoonoses and One Health: A Review of the Literature". Journal of Parasitology Research. 2014: 874345. doi: 10.1155/2014/874345 . ISSN   2090-0023. PMC   3928857 . PMID   24634782.
  18. 1 2 "Zoonotic Diseases One Health CDC". www.cdc.gov. Retrieved 2017-04-05.
  19. "List of zoonotic diseases - GOV.UK". www.gov.uk. Retrieved 2017-04-05.